UNITHROID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Unithroid, and when can generic versions of Unithroid launch?
Unithroid is a drug marketed by Stevens J and is included in one NDA.
The generic ingredient in UNITHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Unithroid
A generic version of UNITHROID was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for UNITHROID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 2 |
Patent Applications: | 2,726 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for UNITHROID |
Drug Sales Revenues: | Drug sales revenues for UNITHROID |
What excipients (inactive ingredients) are in UNITHROID? | UNITHROID excipients list |
DailyMed Link: | UNITHROID at DailyMed |
Recent Clinical Trials for UNITHROID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A |
Children's Hospital of Philadelphia | N/A |
Harvard Medical School (HMS and HSDM) | N/A |
Pharmacology for UNITHROID
Drug Class | l-Thyroxine |